spacer
home > pmps > spring 2017 > paper chase
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Paper Chase

If you were to compare the 21st century pharmaceutical and biotechnology sector with how it started life, you would barely recognise it as the same industry. Its roots go back to when apothecaries and pharmacies offered traditional – but often hit-and-miss – treatments based on old wives’ tales and word of mouth. Today, it is built on a variety of scientific expertise and innovative technologies that are changing the way in which medicines are manufactured. However, despite these advances, many companies are still reliant on processes that are supported by paper documentation and printed forms.

Information scientists have discussed and envisioned the concept of a paperless society – a world in which paper communications and documents are replaced by electronic storage – since the late 1970s, but it is only in recent years that this has become a standard business objective. In the past decade, organisations from almost every industry have committed to becoming ‘greener’, often starting by reducing or eliminating paper-based processes in favour of a digital approach.

By taking advantage of the solutions that today’s technology offers, firms are able to reduce errors, collect accurate records and streamline operations.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Robert Harrison leads the Pharmaceutical Division at COPADATA. With over 20 years of international experience, he has served in varying management and engineering roles across industry and research, gaining his BSc in Electronic Engineering while working at CERN, Switzerland. Robert is currently responsible for driving strategy, technology development, global growth and worldwide performance of zenon technology in the life sciences sector.
spacer
Robert Harrison
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MRC Technology monetises royalties on cancer drug Keytruda (pembrolizumab) to expand medical research activities, with a fund managed by DRI Capital


More info >>

White Papers

Autoinjectors From Planning to Launch

SHL Group

Looking at the rising trend towards self-administration therapies, injectable drug delivery devices such as pen injectors, autoinjectors and needle free injectors show a significant growth potential in the near future. In 2010, the pen systems and autoinjectors market was estimated to be worth over $0.58bn, a growth of 8-10% from previous years. It is estimated that the market will continue to grow steadily between 10-15% over the forecast period. It will reach $0.87bn in 2013 and $1.07bn in 2015. (Visiongain, June, 2011)
More info >>

 
Industry Events

Pharmaceutical Microbiology East Coast

13-14 November 2017, Renaissance Woodbridge Hotel, New Jersey

Drawing on from the huge success of SMi’s Pharmaceutical Microbiology event series, SMi is delighted to announce the launch of Pharmaceutical Microbiology East Coast. Being the eighth in its series, this event will take place in New Jersey, USA, on November 13th and 14th 2017. Aimed at Microbiologists, Quality Control and Quality Assurance Managers, Pharmaceutical Microbiology East Coast 2017 will address the best practices for rapid microbial and sterility testing and tackle the challenges of contamination control.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement